CD8A and hepatocellular carcinoma: Immunostaining on the HCC cohort further confirmed that CD8+ T cells were more abundant in IRGPI-low group, while the tumor microenvironment of IRGPI-high group presents a scene of immune desert (Fig. 7A, B).